(19)
(11) EP 0 777 470 A1

(12)

(43) Date of publication:
11.06.1997 Bulletin 1997/24

(21) Application number: 95932713.0

(22) Date of filing: 12.09.1995
(51) International Patent Classification (IPC): 
A61K 9/ 20( . )
A61K 31/ 35( . )
A61K 45/ 08( . )
A61P 1/ 04( . )
A61K 31/ 341( . )
A61K 45/ 06( . )
A61K 47/ 26( . )
(86) International application number:
PCT/EP1995/003572
(87) International publication number:
WO 1996/008238 (21.03.1996 Gazette 1996/13)
(84) Designated Contracting States:
AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
LT LV SI

(30) Priority: 14.09.1994 GB 19940018530

(71) Applicant: GLAXO GROUP LIMITED
Greenford, Middlesex UB6 0NN (GB)

(72) Inventors:
  • BYE, Alan
    Greenford, Middlesex UB6 0HE0HE (GB)
  • EVANS, Jill
    Ware, Hertfordshire SG12 0DPDP (GB)
  • HUCKLE, Paul Derrick
    Ware, Hertfordshire SG12 0DP (GB)
  • LACEY, Laurence Francis
    Greenford, MiddlesexUB6x 0NN (GB)
  • RUE, Peter John
    Elsenham, Bishop's Stortford CM22 6DF (GB)

(74) Representative: Stott, Michael John, et al 
Glaxo Wellcome plc, Glaxo Wellcome House, Berkeley Avenue
Greenford, Middlesex UB6 0NN
Greenford, Middlesex UB6 0NN (GB)

   


(54) USE OF PARACELLULAR ABSORPTION ENHANCERS SUCH AS GLUCOSE FOR ENHANCING THE ABSORPTION OF HISTAMINE H2-ANTAGONISTS